Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Debt / NOTE 1.000%11/1
-
Market price (% of par)
-
99.04%
-
Total 13F principal
-
$555,020,400
-
Principal change
-
-$23,839,000
-
Total reported market value
-
$550,590,387
-
Number of holders
-
53
-
Value change
-
-$25,155,394
-
Number of buys
-
20
-
Number of sells
-
19
Institutional Holders of ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 as of Q1 2018
As of 31 Mar 2018,
ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 was held by
53 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$555,020,400
in principal (par value) of the bond.
The largest 10 bondholders included
Allianz Asset Management GmbH, ADVENT CAPITAL MANAGEMENT /DE/, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), WOLVERINE ASSET MANAGEMENT LLC, Linden Advisors LP, STEELHEAD PARTNERS LLC, TENOR CAPITAL MANAGEMENT Co., L.P., MACKAY SHIELDS LLC, CITADEL ADVISORS LLC, and CALAMOS ADVISORS LLC.
This page lists
53
institutional bondholders reporting positions
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.